pubmed-article:18609087 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0005953 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0023473 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C2350570 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0062534 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0178587 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0237881 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0220901 | lld:lifeskim |
pubmed-article:18609087 | lifeskim:mentions | umls-concept:C0750502 | lld:lifeskim |
pubmed-article:18609087 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:18609087 | pubmed:dateCreated | 2008-11-12 | lld:pubmed |
pubmed-article:18609087 | pubmed:abstractText | The aims of the study were: (1) to perform a complex angiogenic assessment in chronic myeloid leukaemia (CML) patients using multiple parameters: bone marrow microvessel density (MVD), bone marrow immunohistochemical cellular expressions of vascular endothelial growth factor (VEGF) and its receptor KDR, as well as hepatocyte growth factor (HGF) and its receptor MET, and the plasma VEGF and HGF; and (2) to determine the clinical significance of these factors for patients with CML. | lld:pubmed |
pubmed-article:18609087 | pubmed:language | eng | lld:pubmed |
pubmed-article:18609087 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:18609087 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:18609087 | pubmed:issn | 1502-7686 | lld:pubmed |
pubmed-article:18609087 | pubmed:author | pubmed-author:IvanovaLL | lld:pubmed |
pubmed-article:18609087 | pubmed:author | pubmed-author:GerchevaLL | lld:pubmed |
pubmed-article:18609087 | pubmed:author | pubmed-author:TonchevA BAB | lld:pubmed |
pubmed-article:18609087 | pubmed:author | pubmed-author:ZhelyazkovaA... | lld:pubmed |
pubmed-article:18609087 | pubmed:author | pubmed-author:KolovaPP | lld:pubmed |
pubmed-article:18609087 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:18609087 | pubmed:volume | 68 | lld:pubmed |
pubmed-article:18609087 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:18609087 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:18609087 | pubmed:pagination | 492-500 | lld:pubmed |
pubmed-article:18609087 | pubmed:dateRevised | 2010-11-18 | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:meshHeading | pubmed-meshheading:18609087... | lld:pubmed |
pubmed-article:18609087 | pubmed:year | 2008 | lld:pubmed |
pubmed-article:18609087 | pubmed:articleTitle | Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia. | lld:pubmed |
pubmed-article:18609087 | pubmed:affiliation | Department of Clinical Haematology, University Hospital St. Marina Varna, Varna University of Medicine, Varna, Bulgaria. azhelyazkova@gmail.com | lld:pubmed |
pubmed-article:18609087 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:18609087 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |